Stock Analysis of Adial Pharmaceuticals Inc (ADIL) - Birds Eye View

1W   2W   1M   3M   1Y   2Y   5Y   
Overview
Code ADIL
Close 1.55
Change 0.140 / 9.93 %
Volume 137393
Vol Change 58075.00 / 73.22 %
IndustryBiotechnology
SectorHealthcare
AIO Strength Index
Technical StrengthMild Bearish
Growth Index Low Growth Stock
Value Index Very Low Value Stock
Profitability Index Poor Profitability Stock
Stability Index Excellent Stability


Fundamental View of Adial Pharmaceuticals Inc
PE (TTM)

-0.302

Very Poor
Price / Book

0.534

Very Good
Price / Sales

47.89

Very Poor
Piotroski F Score

2.0

Poor
Market Cap

6285.03 K

Enterprise Value

3457.95 K

ROA (TTM)

-121.53

Very Poor
ROE (TTM)

-176.69

Very Poor
Net Margin (TTM)

-15842.12

Very Poor
Revenue

%

0
Net Profit

52.32 %

-6069.70 K
Debt to Equity

0

Excellent
Altman Z Score

-18.75

Very Poor
Quick Ratio

0

Poor
Cash Ratio

4.33

Very Good


Highs/Lows of Adial Pharmaceuticals Inc
PeriodOld priceStock ReturnS&P 500 ReturnsHighLowHigh DateLow Date
One Week1.5 3.33 % 1.54 % 1.591.313-May-2415-May-24
Two Week1.7 8.82 % 3.42 % 1.74711.306-May-2415-May-24
One Month2.32 33.19 % 5.60 % 2.31.318-Apr-2415-May-24
Three Month1.15 34.78 % 5.95 % 4.16990.76501-Mar-2423-Feb-24
Six Months2.1 26.19 % 17.48 % 4.16990.76501-Mar-2423-Feb-24
One year8.35 81.44 % 27.52 % 14.00.76511-Jul-2323-Feb-24
Two year37.0 95.81 % 29.70 % 15.00.76507-Mar-2323-Feb-24
Five year56.5 97.26 % 85.46 % 15.00.207-Mar-2313-Dec-22


Technical View of Adial Pharmaceuticals Inc
RSI

46.71

Neutral
MACD

-0.085

Bearish
ADX

15.15

Neutral
Super Trend

1.98

Strong Bearish
Williams %R

-59.68

Mild Bullish
CCI

-68.97

Mild Bullish


EMA 5

1.49

Bullish
EMA 15

1.58

Mild Bearish
EMA 50

1.66

Strong Bearish
EMA 100

1.82

Strong Bearish
SMA 100

1.58

Whipsaw
SMA 200

2.19

Mild Bearish
SMA 5 / 20

1.45 / 1.62

Mild Bearish
SMA 15 / 50

1.59 / 1.69

Strong Bearish
SMA 50 / 200

1.69 / 2.19

Mild Bearish




Charts of Adial Pharmaceuticals Inc


Returns of Adial Pharmaceuticals Inc with Peers
Period / StockADILCJJDAIMDLGVN
1 Week3.33%19.56%-1.02%-12.03%
1 Mth-33.19%0.976%0%-38.76%
3 Mth34.78%-35.50%25.30%-75.85%
6mth-26.19%-27.03%-65.33%-93.26%
1 Year-81.44%-81.73%-70.37%-95.79%
2 Year-95.81%-91.92%-95.54%-98.60%
5 Years-97.26%-98.88%13766.67%-
charts-
View All Together in Chart      Inline           Tile

Compare Fundamentals of Adial Pharmaceuticals Inc with Peers
Ratio / StockADILCJJDAIMDLGVN
PE-0.302-0.169-0.321-31.45
P/B0.5340.1900.16777.28
ROA-121.53-22.18-43.66-149.53
ROE-176.69-104.88-52.02-245.73
Debt To Equity01.910.2440.088
Revenue0
% 		148811 K
9.48 % 		1140.23 K
67.60 % 		767000
37.23 %
Net Income-6069.70 K
52.32 % 		-21138.53 K
562.21 % 		-9977.06 K
28.92 % 		-19842.00 K
5.35 %


Technicals of Adial Pharmaceuticals Inc with Peers
Technical / StockADILCJJDAIMDLGVN-
ADX15.1516.7232.0418.55
CMF-0.2150.413-0.118-0.376
MFI52.0571.4281.2547.69
RSI46.7157.9746.3431.71
MACD Abv SignalFalseTrueTrueTrue
Price Above 50 MAFalseTrueFalseFalse-
Price Above 200 MAFalseFalseFalseFalse-


About : Adial Pharmaceuticals Inc

Address : 1180 Seminole Trail, Charlottesville, VA, United States, 22901
Tel : 434 422 9800
URL : https://www.adialpharma.com
Code : ADIL, ISIN : US00688A1060, Exchange : NASDAQ, Country : USA
Fiscal Year End : December
IPO date : 30_Jul_2018
Employee Count : 4

Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. The company's lead product is AD04, a serotonin-3 antagonist, which is in Phase 3 clinical trials for the treatment of alcohol use disorder. It is also involved in the development of drug candidates for non-opioid pain reduction and other diseases and disorders. The company was founded in 2010 and is based in Glen Allen, Virginia.


Note : All Data Generated at the End of Trading Hours (EOD Data)